Burjeel Holdings IPO

Burjeel Holdings is a leading MENA private healthcare services provider known for its quality and clinical excellence, operating an integrated network of hospitals and medical centers across the UAE and Oman.

How To Subscribe

Our

Story

On 12 September 2022, Burjeel Holdings announced its intention to float on the Abu Dhabi Securities Exchange (ADX). This section of our website, Our IPO, contains more information about our business, our planned Initial Public Offering (IPO) and the steps you need to take to participate in the IPO. Founded in 2007, Burjeel Holdings is a leading MENA private healthcare provider, operating as an integrated network across primary, secondary, tertiary and quaternary care. With a network of 39 hospitals and medical centers, Burjeel Holdings is the largest private healthcare provider in the UAE by numbers of beds and number of doctors employed. Burjeel Holdings has an in-patient market share of approximately 17%¸the leading position in the UAE, and an out-patient market share of approximately 12%. Burjeel Holdings had a total bed capacity of 1,316 beds as at 30 June 2022. Across our healthcare brands, Burjeel, Medeor, LLH, Lifecare and Tajmeel, Burjeel Holdings treated 105,000 in-patients and 4.3 million out-patients in 2021.

story

Key Milestones in our Growth

2007

Test

2008

LLH Hospital, Musaffah

Launched our multi-specialty hospital to provide affordable care in the industrial district of Musaffah, Abu Dhabi.

2012

Lifecare Hospital, Baniyas

Launched our multi-specialty hospital to offer medical care in the industrial area of Abu Dhabi.

2013

Tajmeel Kids Park Medical Center, Abu Dhabi

Launched our premier medical center to provide comprehensive medical care for children and adolescents.

2015

Medeor Hospital, Abu Dhabi & Dubai

Opened two multi-specialty hospitals offering affordable, quality healthcare in a friendly environment.

2017

Burjeel Day Surgery Center, Abu Dhabi

Launched our day surgery center designed to help patients get back to their lives quickly and comfortably.

2019

Burjeel Specialty Hospital, Sharjah

Launched our multi-specialty hospital to provide the highest level of care and comfort to the people of the Sharjah region.

2022

Burjeel Farha, Al Ain

Launched the first comprehensive fetal medicine center in the region for diagnosing and treating fetal disorders.

2022

Announced Kingdom of Saudi Arabia expansion

Announced our MoU with the KSA Ministry of Investment and our intention to seek opportunities to invest up to USD $1.0 billion in KSA by 2030.

2007

LLH Hospital, Abu Dhabi

Launched our multi-specialty hospital providing affordable care in Abu Dhabi.

2012

Burjeel Hospital, Abu Dhabi

Launched our quaternary care multi-specialty hospital in Abu Dhabi.

2013

Burjeel Hospital for Advanced Surgery, Dubai

Launched our advanced microsurgery and orthopedic center, providing access to advanced care in the UAE.

2014

Lifecare Hospital, Musaffah

Launched our multi-specialty hospital to offer medical care in the industrial area of Abu Dhabi.

2016

Tajmeel Specialized Medical Center, Abu Dhabi

Launched our premier medical center offering dermatology, dental and pediatric services.

2018

Burjeel Royal Hospital, Al Ain

Launched our luxurious, state-of-the-art healthcare facility to provide the most advanced medical care.

2020

Burjeel Medical City, Abu Dhabi

Launched our world-class quaternary care hospital providing extensive medical services in a luxurious environment.

2022

Kypros Nicolaides Fetal Medicine & Therapy Center

Launched the first comprehensive fetal medicine center in the region for diagnosing and treating fetal disorders.

Our

Brands

Burjeel Hospital
Medeor Hospital
LLH Hospital

Investment

Highlights

Burjeel Holdings provides a comprehensive healthcare ecosystem to patients across the full socio-economic spectrum under the Burjeel, Medeor, LLH, Lifecare and Tajmeel brands, each of which is positioned to serve a different target market demographic.

Key

Metrics

as of September 16, 2022

AED 3,924m

Revenue (FY 22)

AED 878m

EBITDA (FY 22)

AED 355m

Net Profit (FY 22)

23

Medical Centers

16

Hospitals

5.6m

Patients Treated

Our

Leadership

Dr. Shamsheer Vayalil
Dr. Shamsheer Vayalil

Chief Executive Officer and Executive Director

Dr. Shamsheer Vayalil is the Founder and CEO of Burjeel Holdings, the leading healthcare provider in the UAE. An entrepreneur and philanthropist, Dr. Shamsheer set up the first hospital, LLH Hospital, in Abu Dhabi in 2007 to address a gap in top-quality tertiary care in the UAE. In the last 15 years, Dr. Shamsheer has tirelessly worked to build one of the largest and most dynamic healthcare companies in the Gulf and the Middle East. Through Dr. Shamsheer’s vision and strategy, Burjeel Holdings swiftly expanded into diverse brands comprising hospitals, medical centers, homecare and occupational health, and retail pharmacies. During the COVID-19 pandemic, Dr. Shamsheer and Burjeel Holdings have been at the forefront of mobilizing advanced healthcare protocols and conducting PCR tests across the UAE, Oman, and India. Under his leadership, Burjeel Holdings has conducted more than 2 million PCR tests, administered over half a million vaccines, and treated over 10,000 in-patients across the UAE and Oman for COVID-19. As the medical partner for the Indian Premier League in 2020 and 2021, and the T20 World Cup in the UAE, Burjeel Holdings successfully maintained the bio-bubble during the tournaments. Dr. Shamsheer has received numerous global and local awards for his continuous pursuit of excellence in developing healthcare, philanthropy, and entrepreneurship across the region. He is the recipient of the Pravasi Bharatiya Samman Award, India’s highest civilian award presented to Non-Resident Indians, and is among the first investors to receive a long-term residency in the UAE and Oman. Dr. Shamsheer is a member of the UAE Medical Council and a member of the advisory committee of the University of Sharjah College of Medicine. Born in Kozhikode in the south Indian state of Kerala, Dr. Shamsheer pursued an MBBS and MD in radiology in India. Growing up in a family environment in his native Kerala, Dr. Shamsheer attributes his inclination for philanthropy to the value system fostered by his parents, where doing charity is an inherent part of the family. He hopes his philanthropic efforts will make a deep impact on public health globally and inspire other young entrepreneurs to follow suit.

team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team
team

Sustainability

“Driven by our pursuit to deliver high-quality and accessible healthcare, we have placed sustainability at the heart of our decision-making framework. We continually strive to enhance the positive impact of our operations and deliver long-term value for all our stakeholders.” – By Dr. Shamsheer Vayalil, Chief Executive Officer and Executive Director.

Burjeel Holdings is committed to improving its ESG performance, implementing initiatives and making investments that elevate the performance of its businesses, while reducing environmental impacts, adding value to its communities and employees, and ensuring strong governance across the business.

IPO

Timeline

14 September 2022

ITF announcement

6 October 2022

Closing date of the first tranche (retail investors)

10 October 2022

Announcement of final offer price

13 October 2022

Commencement of subscriber refunds

26 September 2022

Subscriptions open and price range announcement

7 October 2022

Closing date of the second tranche (professional investors)

13 October 2022

SMS confirmation to all successful subscribers

14 October 2022

Expected date of listing the shares on ADX

How to

Subscribe?

To subscribe to the Burjeel Holdings IPO please follow the below steps. Further detailed information can be found in the prospectus.

Frequently Asked

Questions

For further information, please refer to the full list of FAQs under the IPO Documents & Download's section.

Receiving

Banks

ADIB
Leading Receive Bank
View Details

Contact

Us

Registered office

402-DO2
15th Floor
Al Sarab Tower
Abu Dhabi Global Market Square
Al Maryah Island, Abu Dhabi
United Arab Emirates

ADX

Emirates NBD Bank PJSC
800 BURJ IPO (800 2875 476)

Investor Relations Enquiries

Chetan Sehgal
Head of Investor Relations
ir@burjeelholdings.com
+971 (0) 230 4111

Media Enquiries

Andy Parnis
Managing Director – Teneo
Andy.parnis@teneo.com
+971 (0) 58 581 4954